Gleamer announces the CE-certification of BreastView, its cutting-edge AI application for breast cancer detection.

BreastView leverages novel AI techniques to deliver fast, precise, and actionable insights that make early detection more achievable than ever.

Gleamer's recent study on BreastView shows that achieving a diagnostic accuracy beyond that of an expert is possible.

With such a high prevalence of breast cancer, it's critical to detect it early. An AI-assisted workflow means more confident diagnoses and better outcomes for patients.